Fluorizoline

Overview

Fluorizoline selectively and directly binds to prohibitin 1 ( PHB1 ) and 2 ( PHB2 ), and induces apoptosis . Fluorizoline reduces chronic lymphocytic leukemia (CLL) cell viability through the upregulation of NOXA and BIM . Fluorizoline exerts antitumor action in a p53-independent manner.

Application

Products | Products > Disease Areas > Digestive System Inflammation | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-114989
• CAS No.: 1362243-70-6
• Molecular Formula: C15H8Cl2F3NS
• Molecular Weight: 362.20
• Purity: 99.77%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: 2.5 mg/mL (6.90 mM); Suspended solution; Need ultrasonic
• Availability: In-stock

Source

Original product source